IMMUNITYBIO, INC. (IBRX) Operating cash flow 2016–2025
IMMUNITYBIO, INC. (IBRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$304.9MFY2025 · since FY2016: -$38.6M → -$304.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$304.9M | +22.1% |
| FY2024 | -$391.2M | -6.7% |
| FY2023 | -$366.8M | -8.7% |
| FY2022 | -$337.5M | -23.0% |
| FY2021 | -$274.4M | -59.8% |
| FY2020 | -$171.7M | -12.9% |
| FY2019 | -$152.1M | -140.0% |
| FY2018 | -$63.4M | -29.9% |
| FY2017 | -$48.8M | -26.4% |
| FY2016 | -$38.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice